Tag: Perioperative

Studies show that nearly 60% of inpatients exhibit at least one abnormal vital sign within four hours of a cardiac arrest, highlighting the predictive power of these measurements [1.6.3]. This statistic underscores **why do we take vital signs before surgery**: to establish a crucial baseline for patient safety.

According to research published in the *Journal of Emergency and Critical Care Medicine*, intraoperative hypotension during general anesthesia is a common event linked to complications such as organ injury. Understanding how **does general anesthesia affect BP** is critical, as anesthesiologists meticulously manage these changes throughout any procedure.

In many cases, a consensus statement recommends stopping Plavix (clopidogrel) at least 5 days before most elective surgery to minimize the risk of excessive bleeding. However, the exact timeline for how long do you need to be off Plavix for surgery is a personalized decision that must carefully weigh the risks of surgical bleeding against the potential for dangerous blood clots.

For patients on antiplatelet medication, premature discontinuation of clopidogrel has been associated with a five- to tenfold increase in the risk of cardiovascular events and death in those with recent stent placement. Determining exactly when to restart clopidogrel post-op requires carefully weighing the risk of surgical bleeding against the risk of potentially life-threatening thrombotic events. This decision is never a one-size-fits-all approach and depends on numerous factors unique to each patient and procedure.

With an aging population, the number of patients taking antiplatelet agents who require surgery is steadily increasing. Navigating the perioperative period involves a critical and patient-specific decision: when to restart antiplatelets after surgery? The timing balances the risk of a new blood clot forming against the risk of surgical bleeding.

With an extremely short initial phase half-life of just one minute, CLEVIPREX (clevidipine) offers rapid and precise blood pressure reduction for critically ill patients. This article explains what does CLEVIPREX do and how its unique pharmacological profile addresses severe hypertension in controlled clinical settings.